60 /100
HIGH RISK
Score updated May 30, 2026

SDOT — Sadot Group Inc. Dilution Risk Tracker

Track SDOT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SDOT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
58%
📜 Warrant Exercise 60%
• Massive warrant overhang: 161% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion 60%
• Major convertible overhang: 231% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 50%
• Score rose 40 points recently (worsening)
• Score in HIGH risk zone (60/100)
🔔 Track SDOT — Get forecast alerts →

💹 Market Data

Market Cap$2.03M
Shares Outstanding744.0K
Float665.9K
Cash$409.0K
Debt$11.17M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 65.0% shares (2025Q4 vs prior)
1 institutional holders · 35.0K shares
#1 Sanctuary Advisors, LLC 35.0K shares

📉 Short Interest

Short Interest154.1K
Days to Cover1.0
% of Float23.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Dec 31, 2024
8-K 8K EVENT Apr 15, 2026
8-K 8K EVENT Feb 12, 2026
8-K 8K EVENT Feb 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SDOT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SDOT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SDOT
📊 SDOT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SDOT Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SDOT Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.